Lundbeck
HLUN-B.CO
#2235
Rank
NZ$15.15 B
Marketcap
NZ$15.27
Share price
1.52%
Change (1 day)
19.53%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): NZ$0.58

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.36. In 2022 the company made an earnings per share (EPS) of NZ$0.48 a decrease over its 2021 EPS that were of NZ$1.08.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$0.5821.19%
2022NZ$0.48-55.47%
2021NZ$1.08-51.83%
2020NZ$2.24-28.01%
2019NZ$3.11-44.08%
2018NZ$5.5751.94%
2017NZ$3.67126.64%
2016NZ$1.62-120.84%
2015NZ-$7.765622.18%
2014NZ-$0.14-110.03%
2013NZ$1.35-28.08%
2012NZ$1.88-52.1%
2011NZ$3.92-1.31%
2010NZ$3.9815.61%
2009NZ$3.44